| Literature DB >> 35953737 |
Prita Daliya1, Jody Carvell2, Judith Rozentals2, Dileep N Lobo3,4, Simon L Parsons2,1.
Abstract
BACKGROUND: Although recommendations exist for patients to be offered a post-operative helpline or telephone follow-up appointment at discharge after cholecystectomy, implementation of these is resource-intensive. Whilst the benefits of telephone follow-up are well documented, the use of digital modalities is less so. We aimed to identify if digital follow-up (DFU) was equivalent to routine care with telephone follow-up (TFU), for patients undergoing elective laparoscopic cholecystectomy.Entities:
Mesh:
Year: 2022 PMID: 35953737 PMCID: PMC9371370 DOI: 10.1007/s00268-022-06684-w
Source DB: PubMed Journal: World J Surg ISSN: 0364-2313 Impact factor: 3.282
Seven-day follow-up survey
| Categories | Questions | Possible responses | Score | |
|---|---|---|---|---|
| 1 | 1 | How would you rate your general well-being since your operation? | Better than before my operation | 0 |
| Almost back to normal | 0 | |||
| Back to normal | 0 | |||
| Worse than before my operation, but getting better | 1 | |||
| Worse than before my operation, and not getting better | 3 | |||
| 2 | 2 | Have you had to seek medical advice (from hospital, your GP, or a nurse) regarding anything to do with your operation since you were discharged from hospital care? | No | 0 |
| Yes | 1 | |||
| 3 | Is the problem better now? | No | 2 | |
| Yes | 0 | |||
| 3 | 4 | How much pain are you in following your operation? | None | 0 |
| Mild | 0 | |||
| Moderate | 1 | |||
| Severe | 2 | |||
| 5 | Which painkillers are you still currently needing for pain after your operation? | None | 0 | |
| Paracetamol | 0 | |||
| Ibuprofen/co-codamol | 0 | |||
| Tramadol/codeine/dihydrocodeine | 1 | |||
| Morphine of similar | 2 | |||
| 4 | 6 | Bowel motions (stool) can change after an operation. Which term best describes them now? | Normal | 0 |
| Loose (diarrhoea) | 1 | |||
| Hard (constipation) | 1 | |||
| Not been able to pass stool or flatus (wind from the back passage) since the operation | 3 | |||
| 5 | 7 | Have your stools become pale since your operation (yellow or white)? | No | 0 |
| Yes | 1 | |||
| 8 | Have you noticed any yellow discolouration of your eyes/skin (jaundice)? | No | 0 | |
| Yes | 1 | |||
| 9 | What colour is your urine? | Normal | 0 | |
| Clear | 0 | |||
| Dark | 1 | |||
| 6 | 10 | Are any of your wounds red and hot? | No | 0 |
| Yes | 1 | |||
| 11 | If you have discharge from your wound/s, is the discharge volume such that you are having to change your dressings 2 or more times daily? | No discharge | 0 | |
| No | 0 | |||
| Yes | 1 | |||
| 12 | What colour is the discharge from your wound/s? | No discharge | 0 | |
| Clear | 0 | |||
| Red | 0 | |||
| Yellow | 1 | |||
| Green | 3 | |||
| Brown | 3 | |||
Fig. 1Participant recruitment (STROBE diagram). DNA: Did not attend (patient missed their appointment despite prompting). *Non-standard operation = open cholecystectomy, laparoscopic cholecystectomy combined with another operation such as liver resection or gastric bypass. **Excluded = follow-up performed at ≥ 31 days post-operatively
Demographics in participants offered follow-up versus those not offered follow-up
| Follow-up versus no follow-up | Digital versus telephone follow-up | |||||
|---|---|---|---|---|---|---|
| Follow-up | No follow-up | Digital follow-up | Telephone follow-up | |||
| Mean (SD) | 46.8 (15.2) | 48.8 (15.2) | 0.140* | 44.9 (14.6) | 48.1 (15.6) | 0.197* |
| IQR | 35.0–59.0 | 35.9–59.7 | 32.5–55.3 | 35.4–1.0 | ||
| Female | 171 (81.4) | 256 (85.3) | 0.273† | 66 (77.6) | 105 (84.0) | 0.280† |
| Male | 39 (18.6) | 44 (14.7) | 19 (22.3) | 20 (16.0) | ||
| 0 | 162 (77.1) | 229 (76.3) | 0.968‡ | 71 (83.5) | 91 (72.8) | 0.186‡ |
| 1 | 25 (11.9) | 35 (11.7) | 14 (16.5) | 32 (25.6) | ||
| 2 | 13 (6.2) | 22 (7.3) | 0 | 2 (1.6) | ||
| ≥ 3 | 10 (4.8) | 14 (4.7) | 3 (3.5) | 7 (5.6) | ||
| Median (IQR) | 29.6 (25.9–34.5) | 29.4 (25.9–34.7) | 0.796* | 29.0 (25.0–35.0) | 30.1 (27.0–34.0) | 0.170* |
| < 18.5 | 1 (6.8) | 2 (0.7) | 0.353‡ | 1 (1.2) | 0 | 0.211‡ |
| 18.5–24.9 | 41 (19.5) | 52 (17.3) | 22 (25.9) | 19 (15.2) | ||
| 25.0–29.9 | 65 (30.9) | 103 (34.3) | 24 (28.2) | 41 (32.8) | ||
| 30.0–34.9 | 54 (25.7) | 63 (21.0) | 17 (20.0) | 37 (29.6) | ||
| 35.0–39.9 | 30 (14.3) | 55 (18.3) | 13 (15.3) | 17 (13.6) | ||
| ≥ 40.0 | 18 (8.6) | 15 (5.0) | 7 (8.2) | 11 (8.8) | ||
| Missing | 1 (6.8) | 10 (3.3) | 1 (1.2) | 0 | ||
| 0 | 137 (65.2) | 190 (63.3) | < 0.001‡ | 55 (64.7) | 82 (65.6) | 1.000† |
| 1 | 68 (32.4) | 70 (23.3) | 28 (32.9) | 40 (32.0) | ||
| 2 | 1 (0.5) | 14 (4.7) | 1 (1.2) | 0 | ||
| ≥ 3 | 4 (1.9) | 26 (8.7) | 1 (1.2) | 3 (2.4) | ||
Values expressed as number (%), unless otherwise stated
SD standard deviation, IQR inter-quartile range, CCI Charlson Comorbidity Index, BMI Body Mass Index
*Mann–Whitney U test
†Fisher’s exact test
‡Chi-square test
30-Day complications identified by participant follow-up, compared with those seen in no follow-up group
| Follow-up versus no follow-up | Digital versus telephone follow-up | |||||
|---|---|---|---|---|---|---|
| Follow-up | No follow-up | Digital follow-up | Telephone follow-up | |||
| 30-day complications | 47a (27.4) | 27 (9.0) | < 0.001 | 15b (17.6) | 32c (25.6) | 0.183 |
| Specific: | 36 (17.1) | 23 (7.7) | 0.001 | 10 (11.8) | 26 (20.8) | 0.096 |
| Intra-operative | 0 | 1 (0.3)* | 1 | 0 | 0 | – |
| Common bile duct injury | 0 | 1 (0.3) | 1 | 0 | 0 | – |
| Bile leak | 0 | 1 (0.3) | 1 | 0 | 0 | – |
| Gallbladder bed collection | 1 (0.5) | 2 (0.7) | 1 | 1 (1.2) | 0 | 0.405 |
| Acute pancreatitis | 0 | 2 (0.7) | 0.515 | 0 | 0 | – |
| Port-site wound infection | 27 (12.9) | 7 (2.3) | < 0.001 | 5 (5.9) | 22 (17.6) | 0.012 |
| Port-site wound dehiscence | 0 | 4 (1.3) | 0.147 | 0 | 0 | – |
| Persistent post-operative pain | 8 (3.8) | 5 (1.7) | 0.158 | 4 (4.7) | 4 (3.2) | 0.717 |
| Generic: | 11 (5.2) | 4 (1.3) | 0.015 | 5 (5.9) | 6 (4.8) | 0.76 |
| Constipation | 8 (3.8) | 1 (0.3) | 0.004 | 4 (4.7) | 4 (3.2) | 0.717 |
| Diarrhoea | 1 (0.5) | 1 (0.3) | 1 | 1 (1.2) | 0 | 0.405 |
| Other | 2 (0.9) | 2 (0.7) | 1 | 0 | 2 (1.6) | 0.516 |
Values expressed as number (%), unless otherwise stated
†Fisher’s exact test
*Small bowel injury
aTotal of 63 complications, but 16 not identified at follow-up
bTotal of 22 complications, but 7 not identified at follow-up
cTotal of 41 complications, but 9 not identified at follow-up
Readmission, reoperation and mortality in follow-up and no follow-up groups
| Follow-up versus no follow-up | Digital versus telephone follow-up | |||||
|---|---|---|---|---|---|---|
| Follow-up | No Follow-up | Digital follow-up | Telephone follow-up | |||
Total complications at 30-days Identified complications at 30-days | 63 47 | 27 n/a | < 0.001† | 22 (25.9) 15 (17.6) | 41 (32.8) 32 (25.6) | 0.183† |
Total re-attendances at 30-days Identified readmissions at 30-days | 15 (7.1) 3 (1.4) | 24 (8.0) n/a | 0.866† | 6 (7.1) 3 (3.5) | 9 (7.2) 0 | 1.000† |
| Length of stay | ||||||
| (median days) | 0 | 4 | 0.134* | 0 | 0 | 0.908* |
| (IQR) | 0–3.0 | 0.5–6.7 | 0–4.0 | 0–3.5 | ||
Total reoperations at 30-days Identified reoperations at 30-days | 2 (0.9) 0 | 5 (1.7) n/a | 0.705† | 1 (1.2) 0 | 1 (0.8) 0 | 1.000† |
| Mortality | 0 | 0 | – | 0 | 0 | – |
Values expressed as number (%), unless otherwise stated
*Mann–Whitney U test
†Fisher’s exact test
30-day post-operative complications not identified at follow-up
| Participant | Complication | Complication identified on post-op day | Follow-up on post-op day | Outcome | Readmission LOS (days) | |
|---|---|---|---|---|---|---|
| 1 | Post-op bleed | 1 | before FU | 14 | Laparoscopy and washout | 7 |
| 2 | Persistent pain | 3 | before FU | 31 | Review and advice | 0 |
| 3 | Chest infection | 13 | after FU | 12 | Review and antibiotics | 0 |
| 4 | Stitch sinus | 24 | after FU | 6 | Review and stitch removal | 0 |
| 5 | Constipation | 26 | after FU | 13 | Review and laxatives | 0 |
| 6 | Wound infection | 27 | after FU | 5 | Review and antibiotics | 0 |
| 7 | Wound infection | 29 | after FU | 8 | Review and abscess drainage | 0 |
| 8 | Wound dehiscence | 1 | before FU | 8 | Review and wound closure | 0 |
| 9 | PONV | 2 | before FU | 8 | Review, fluids and antiemetics | 2 |
| 10 | Bile leak | 5 | before FU | 12 | Laparoscopy and washout | 4 |
| 11 | Collection | 5 | before FU | 22 | Review and advice | 0 |
| 12 | Pain | 5 | before FU | 22 | Review and antibiotics | 3 |
| 13 | Wound infection | 7 | before FU | 23 | Review and abscess drainage | 4 |
| 14 | Pain | 10 | before FU | 23 | Review and advice | 0 |
| 15 | Pain | 13 | before FU | 16 | Review and advice | 0 |
| 16 | Wound infection | 13 | after FU | 12 | Review and antibiotics | 0 |
Post-op: post-operative, LOS: length of stay, FU: follow-up, PONV: post-operative nausea and vomiting
Fig. 2a Complications identified by digital follow-up survey: category scores. Cumulative scores for each category of the post-operative digital follow-up questionnaire. Scores ≥ 3 (shown in red) for each category triggered participants to have telephone follow-up. b Complications identified by digital follow-up survey: total scores. Cumulative scores for all 12 questions of the post-operative digital follow-up questionnaire. Scores ≥ 9 (shown in red) overall triggered participants to have telephone follow-up